In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...

Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early ...

AlphaFold, which predicts three-dimensional, bioactive forms of a protein, has millions of sequences and a couple of hundred thousand structures. It can tell you, based on a particular pattern, what ...

Several patient and disease advocacy organizations have responded to the Center for Drug Evaluation and Research's (CDER) ...

A program designed to conduct drug development clinical trials for a psychedelic drug in Texas hit a road bump after the ...

Cancer drugs known as BET inhibitors once looked like a breakthrough, but in real patients they’ve often fallen short. New ...

Nancy L. Lewis, MD, MBS, FACP, reflects on the career journey that led her to her new role as chief scientific officer (CSO) ...

In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...

Master ultra-high-throughput screening principles. Learn how advanced automation and miniaturization accelerate drug ...

Kelly Chibale says that the hunt for new drugs is kind of like a fairy-tale quest. And it takes a lot of time and patience. "It doesn't mean that there aren't surprises or miracles," he says. "They do ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

AI and digital tools are shifting quality oversight in the pharmaceutical industry from retrospective testing to real-time, ...